Capitainer News

Patent on the novel Capitainer B product approved in the US

Press release | November 2018

Patent on the novel Capitainer B product approved in the US

Capitainer-B – “effectively assist in eliminating the hematocrit-based area bias”

Press release | October 2018

Capitainer-B – “effectively assist in eliminating the hematocrit-based area bias”

Capitainer participates in (IATDMCT) Congress 2018, 16–19 September 2018 in Brisbane, Australia

Events | August 2018

Capitainer participates in (IATDMCT) Congress 2018, 16–19 September 2018 in Brisbane, Australia

Meet us at AACC Annual Scientific Meeting

Events | July 2018

Meet us at AACC Annual Scientific Meeting

Capitainer B is CE-marked and is being made available for the European market!

Press release | June 2018

Capitainer B is CE-marked and is being made available for the European market!

Ernst Westman new Chairman of the Board

Press release | November 2017

Ernst Westman new Chairman of the Board

Capitainer receives 10 million SEK in initial funding round

Press release | May 2017

Capitainer receives 10 million SEK in initial funding round

Capitainer Awarded 2 M SEK

Press release | January 2016

Capitainer Awarded 2 M SEK